000 01063nam a2200301 a 4500
005 20250914134225.0
008 040818s2004 xxka b 001 0 eng b
020 _a1841842923
_cRM559.50
039 9 _a200505261610
_blailawati
_c200505241118
_dzainol
_c200505171037
_dzainol
_y08-18-2004
_zfida
060 _aQU85
090 _aQU85.S797 2004
245 0 0 _aStatins :
_bthe HMG-CoA reductase inhibitors in perspective /
_cedited by Allan Gaw, Christopher J. Packard, James Shepherd
250 _a2nd ed.
260 _aLondon :
_bMartin Dunitz,
_c2004
300 _aviii, 262 p. :
_bill. ;
_c26 cm.
650 2 _aAntilipemic Agents
650 2 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
650 2 _aHyperlipidemia
700 1 _aGaw, Allan
700 1 _aPackard, Christopher J.
700 1 _aShepherd, J.
_q(James),
_d1944-
907 _a.b13419560
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQU85.S797 2004
914 _avtls003293775
991 _aJabatan Farmasi
998 _ad
_b2004-05-08
_cm
_da
_feng
_gxxk
_y0
_z.b13419560
999 _c341239
_d341239